GSK shared new Phase III data on Arexvy, its RSV vaccine, at the 2024 CHEST annual meeting. Results show a single dose of ...

Zephyrm Bioscience, a Cayman Islands-based biotech, has filed for an IPO in Hong Kong to fund its cell therapy pipeline. The ...

Johnson & Johnson has halted the late-stage SunRISe-2 study of its bladder cancer drug candidate TAR-200, owing to ...

Privately-held UK biotech Curve Therapeutics has announced the appointment of Rab Prinjha as chief research and development ...

French cancer vaccine focused biotech Oncovita has appointed Dr Stéphane Altaba as its new chief executive (CEO).

Genor Biopharma s set to merge with Edding Group in a reverse takeover valued at 2.8 billion renminbi ($382 million), marking ...

Innovent Biologics (HKEX: 01801) has formed a strategic partnership with ASK Pharm (SZ: 002755) to commercialize limertinib, ...

Israel-based Teva Pharmaceutical Industries today announced that the US Food and Drug Administration (FDA) has accepted, and ...

UK-based Mestag Therapeutics has entered a license and collaboration agreement with Merck & Co to explore new therapies for ...

UK-based AviadoBio, a LifeArc Ventures portfolio company, and Astellas Pharma today announced an exclusive option and license ...

China-headquartered clinical-stage biotech MediLink Therapeutics has announced a global clinical trial collaboration and ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Iqirvo (elafibranor), from French drugmaker ...